Erkki Elonen

7.0k total citations · 1 hit paper
117 papers, 4.0k citations indexed

About

Erkki Elonen is a scholar working on Oncology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Erkki Elonen has authored 117 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 34 papers in Hematology and 30 papers in Pathology and Forensic Medicine. Recurrent topics in Erkki Elonen's work include Lymphoma Diagnosis and Treatment (28 papers), Acute Myeloid Leukemia Research (22 papers) and Acute Lymphoblastic Leukemia research (16 papers). Erkki Elonen is often cited by papers focused on Lymphoma Diagnosis and Treatment (28 papers), Acute Myeloid Leukemia Research (22 papers) and Acute Lymphoblastic Leukemia research (16 papers). Erkki Elonen collaborates with scholars based in Finland, Sweden and Denmark. Erkki Elonen's co-authors include Pertti J. Neuvonen, Sakari Knuutila, Kaarle Franssila, Sakari Knuutila, Tapani Ruutu, Riikka Räty, Mauri J. Mattila, Liisa Volin, David Oscier and Lasse Teerenhovi and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Erkki Elonen

116 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic Subgroups in B-Cell Chronic Lymphocytic Leukemia Defined by Specific Chromosomal Abnormalities

1990 502 citations Sakari Knuutila, Erkki Elonen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erkki Elonen Finland	36	1.4k	1.2k	1.1k	849	807	117	4.0k
Chul Won Jung South Korea	37	947 0.7×	669 0.5×	1.5k 1.4×	1.5k 1.8×	1.4k 1.7×	245	5.0k
Patrick D. Walker United States	42	767 0.6×	312 0.2×	498 0.5×	1.4k 1.7×	352 0.4×	122	5.1k
Lynell W. Klassen United States	39	910 0.7×	329 0.3×	547 0.5×	704 0.8×	675 0.8×	137	5.0k
Hisashi Tsurumi Japan	37	943 0.7×	266 0.2×	909 0.8×	1.1k 1.3×	348 0.4×	201	3.7k
Christian Datz Austria	43	572 0.4×	909 0.7×	544 0.5×	877 1.0×	1.4k 1.8×	176	6.3k
Mario Pirisi Italy	39	754 0.5×	180 0.1×	631 0.6×	680 0.8×	285 0.4×	308	6.1k
Elwyn Elias United Kingdom	52	237 0.2×	347 0.3×	1.2k 1.1×	937 1.1×	362 0.4×	229	8.5k
Y Levo Israel	29	372 0.3×	303 0.2×	320 0.3×	554 0.7×	214 0.3×	147	3.8k
Niels Grunnet Denmark	40	483 0.3×	123 0.1×	343 0.3×	1.1k 1.3×	589 0.7×	217	5.1k
Bas Oldenburg Netherlands	46	409 0.3×	260 0.2×	1.8k 1.7×	999 1.2×	552 0.7×	208	7.7k

Countries citing papers authored by Erkki Elonen

Since Specialization

Citations

This map shows the geographic impact of Erkki Elonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erkki Elonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erkki Elonen more than expected).

Fields of papers citing papers by Erkki Elonen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erkki Elonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erkki Elonen. The network helps show where Erkki Elonen may publish in the future.

Co-authorship network of co-authors of Erkki Elonen

This figure shows the co-authorship network connecting the top 25 collaborators of Erkki Elonen. A scholar is included among the top collaborators of Erkki Elonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erkki Elonen. Erkki Elonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hohtari, Helena, Niels Pallisgaard, Matti Kankainen, et al.. (2022). Copy number alterations define outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia. Haematologica. 107(8). 1971–1976. 1 indexed citations

Mosakhani, Neda, et al.. (2013). MicroRNA Profiling in Chemoresistant and Chemosensitive Acute Myeloid Leukemia. Cytogenetic and Genome Research. 141(4). 272–276. 22 indexed citations

Sarhadi, Virinder Kaur, Leo Lahti, Ilari Scheinin, et al.. (2013). Targeted resequencing of 9p in acute lymphoblastic leukemia yields concordant results with array CGH and reveals novel genomic alterations. Genomics. 102(3). 182–188. 13 indexed citations

Pitkäniemi, Janne, et al.. (2012). Anxiety and pain during bone marrow aspiration and biopsy. Scandinavian Journal of Pain. 3(2). 92–96. 17 indexed citations

Borze, Ioana, Eeva Juvonen, Shinsuke Ninomiya, et al.. (2010). High-resolution oligonucleotide array comparative genomic hybridization study and methylation status of the RPS14 gene in de novo myelodysplastic syndromes. Cancer Genetics and Cytogenetics. 197(2). 166–173. 5 indexed citations

Ninomiya, Shinsuke, Riikka Räty, Jaakko Hollmén, et al.. (2009). Focal 9p instability in hematologic neoplasias revealed by comparative genomic hybridization and single‐nucleotide polymorphism microarray analyses. Genes Chromosomes and Cancer. 49(4). 309–318. 24 indexed citations

Räty, Riikka, Sakari Knuutila, Kim Vettenranta, et al.. (2008). Acute lymphoblastic leukemia in adolescents and young adults in Finland. Haematologica. 93(8). 1161–1168. 75 indexed citations

Jantunen, Esa, Tom Wiklund, Eeva Juvonen, et al.. (2003). Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey. Bone Marrow Transplantation. 33(4). 405–410. 56 indexed citations

Nagy, Bálint, Tuija Lundán, Marcelo L. Larramendy, et al.. (2003). Abnormal expression of apoptosis‐related genes in haematological malignancies: overexpression of MYC is poor prognostic sign in mantle cell lymphoma. British Journal of Haematology. 120(3). 434–441. 89 indexed citations

10.

Ruutu, Tapani, E. Koivunen, T. Nousiainen, et al.. (2003). Oral treatment of acute myeloid leukaemia with etoposide, thioguanine, and idarubicin (ETI) in elderly patients: a prospective randomised comparison with intravenous cytarabine, idarubicin, and thioguanine in the second and third treatment cycle. European Journal Of Haematology. 72(1). 38–44. 8 indexed citations

11.

Andersen, Niels Smedegaard, Lone Bredo Pedersen, Erkki Elonen, et al.. (2003). Primary treatment with autologous stem cell transplantation in mantle cell lymphoma: outcome related to remission pretransplant. European Journal Of Haematology. 71(2). 73–80. 65 indexed citations

12.

Jantunen, Esa, Maija Itälä, Tuula Lehtinen, et al.. (2002). Autologous Stem Cell Transplantation in Patients with Mantle Cell Lymphoma. Leukemia & lymphoma. 43(6). 1229–1237. 13 indexed citations

13.

Elonen, Erkki. (2000). Acute leukaemias in adults. 2 indexed citations

14.

Mustjoki, Satu, Nicolai Sidénius, Cornelis F.M. Sier, et al.. (2000). Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy.. PubMed. 60(24). 7126–32. 89 indexed citations

15.

Plass, Christoph, Feng Yu, Li Yu, et al.. (1999). Restriction landmark genome scanning for aberrant methylation in primary refractory and relapsed acute myeloid leukemia; involvement of the WIT-1 gene. Oncogene. 18(20). 3159–3165. 48 indexed citations

16.

Monni, Outi, Erkki Elonen, Kaarle Franssila, et al.. (1998). Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma. Genes Chromosomes and Cancer. 21(4). 298–307. 105 indexed citations

17.

Lehne, Gustav, Erkki Elonen, M. Baekelandt, Torben Skovsgaard, & Curt Peterson. (1998). Challenging Drug Resistance in Cancer Therapy: Review of the First Nordic Conference on Chemoresistance in Cancer Treatment, October 9th and 10th, 1997. Acta Oncologica. 37(5). 431–439. 18 indexed citations

18.

Knuutila, Sakari, Juha Klefström, J. Szymańska, et al.. (1994). Two novel human B‐cell lymphoma lines of lymphatic follicle origin: Cytogenetic, molecular genetic and histopathological characterisation. European Journal Of Haematology. 52(2). 65–72. 21 indexed citations

19.

Kostiala, A A, et al.. (1987). Serial study of c-reactive protein during fungal esophagitis and enterocolitis. Infection. 15(6). 417–421. 2 indexed citations

20.

Neuvonen, Pertti J. & Erkki Elonen. (1980). Phenobarbitone elimination rate after oral charcoal.. BMJ. 280(6216). 762.1–762. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact